Page 44 - Journal of World Association of Laparoscopic Surgeons
P. 44

Pain Relief After LVHR
            Table 2: Study characteristics of included trials comparing LA interventions for postoperative pain up to 24 hours following LVHR
                                                                Mean morphine
                                                                consumption in
                     Design,                                    24 hours (mg)    Pain score   Mean pain scores at

                     N [intervention/                           [intervention/   measure    rest [intervention/  Main findings
            Study    control]    Intervention    LA agent, control  control]  (0–10)   †  control]   of intervention
                  29
            Bellows   RCT, 9/9   Trans-abdominal LA   10 mL 0.25%   24.1 ± 7.2/   VAS  1 hours: 2.2 ± 0.8/   Significant
                                 injected at suture   bupivacaine with   26.3 ± 9.2  6.4 ± 0.9*      reduction in
                                 sites prior to suture   epinephrine, no            2 hours: 3.1 ± 0.9/   pain scores at
                                 placement       control                            3.9 ± 1.1        one hour after
                                                                                    4 hours: 1.1 ± 0.4/   surgery
                                                                                    2.6 ± 0.9
                                                                                    24 hours: 2.3 ±
                                                                                    0.8/2.3 ± 1.0
                30
            Fields    RCT, 52/48  Laparoscopic assisted  50–60 mL 0.25%   25.64/42.56*  VAS  1 hours: 5.19 ± 0.39/  Significant
                                 TAP block       bupivacaine, 0.9%                  6.46 ± 0.38*     reduction in
                                                 normal saline                      24 hours: 4.60 ±   pain scores and
                                                                                    0.39/4.52 ± 0.31*  total morphine
                                                                                                     consumption in
                                                                                                     24 hours
                 31
            Gough    RCT, 42/38  Peri-prosthetic LA   0.5% bupivacaine,  4.8 ± 17.3/   NRS  <1.5 hours: 4.4 ± 2.4/  Reduced pain
                                 injection, with all   0.9% normal   6.7 ± 15.4     4.8 ± 2.2        scores and total
                                 patients receiving LA  saline                      22.5–24.5 hours:    morphine con-
                                 port site injections                               3.6 ± 2.5/2.7 ± 1.4  sumption (not
                                                                                                     significant)
                 32
            Rosen    RCT, 37/36  Continuous      0.5% bupivacaine,  52.2/44.5  VAS  0:1.7/2.3        No advantage
                                 elastomeric pain   0.9% normal                     8 hours: 5.7/5.5  in reduction
                                 pump infusion of LA   saline                       16 hours: 5.4/5.6  pain scores and
                                 for 48 hours above                                                  total morphine
                                 the mesh in the                                    24 hours: 5.0/6.0  consumption in
                                 hernia sac                                                          24 hours
            VAS, visual analog scale; LA, local anesthetic; LVHR, laparoscopic ventral hernia repair; TAP, transverse abdominis plane; NRS, numerical rating scale; VRS,
            verbal rating score; PPI, present pain intensity; RCT, randomized controlled trial.
            † All pain scores use a 0–10 point scale with a score of 10 signifying the worst possible pain.
            *p <0.05.






























            Fig. 1: Cochrane risk of bias figure






             36   World Journal of Laparoscopic Surgery, Volume 12 Issue 1 (January–April 2019)
   39   40   41   42   43   44   45   46   47   48   49